ADDITIONAL SOUTHERN CALIFORNIA BREAST HEALTH CENTERS ADD DIGNICAP® TO THEIR PATIENT TREATMENT OFFERINGS
Lund, Sweden—October 4, 2016—Dignitana AB, a world leader in medical scalp-cooling technology, announced today that the DigniCap ® scalp cooling system, which was cleared in 2015 by the FDA to effectively reduce the likelihood of chemotherapy-induced hair loss in women with breast cancer, will be available at all five Breastlink centers in the U.S. The DigniCap® system is the first and only scalp cooling device to complete rigorous FDA clinical trials in America, where seven out of ten patients with